Clinical Trials Logo
  1. Home
  2. Growth Hormone Treatment
  3. NCT05195437

Evolution of the Quality of Life of Short Statured Children Treated With Growth Hormone : Evaluation at Adult Size — HF QoL  

Growth Hormone Treatment Clinical Trial

Official title:
Evolution of the Quality of Life of Short Stature Children Treated With Growth Hormone : Evaluation at Adult Size

Clinical Trial Summary

Short stature can lead to emotional and social stress in children and adolescents, as well as their parents. Children and their parents want to be able to identify the cause of stunted growth and address it with treatment. Mitigating the impact of short stature on quality of life is one of the main goals of treatment. The quality of life in children can be measured using adapted self-questionnaires. The investigative team published in 2019 the results of a preliminary study which shows that after one year of treatment with growth hormone, the quality of life improves in children, in particular on the scales emotional and social. These evaluations were carried out in particular thanks to the general questionnaire of quality of life: Pediatric Quality of Life Inventory (PedsQL) 4.0, but also via a specific questionnaire of the size: Quality of Life of Short Stature Youth questionnaire (QoLiSSY). 50 of the 74 patients who participated in this study have now reached their final height. The objective of the present study is to reassess this cohort using the QoLiSSY and PedsQL 4.0 questionnaires. The patient will be his own witness.

Clinical Trial Description

Short stature can lead to emotional and social stress in children and adolescents, as well as their parents. Children and their parents want to be able to identify the cause of stunted growth and address it with treatment. Mitigating the impact of short stature on quality of life is one of the main goals of treatment. The quality of life in children can be measured using adapted self-questionnaires. The investigative team published in 2019 the results of a preliminary study which shows that after one year of treatment with growth hormone, the quality of life improves in children, in particular on the scales emotional and social. These evaluations were carried out in particular thanks to the general questionnaire of quality of life: Pediatric Quality of Life Inventory (PedsQL) 4.0, but also via a specific questionnaire of the size: Quality of Life of Short Stature Youth questionnaire (QoLiSSY). 50 of the 74 patients who participated in this study have now reached their final height. The objective of the present study is to reassess this cohort using the QoLiSSY and PedsQL 4.0 questionnaires. The patient will be his own witness. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05195437
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Completed
Phase
Start date March 8, 2022
Completion date March 7, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT02987868 - Effects of an Amino Acid-Based hGH Secretagogue on Triiodythyronine N/A
Recruiting NCT03431727 - Acromegaly - Before and After Treatment
Completed NCT03038594 - Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients Phase 2/Phase 3
Completed NCT02782221 - Lipolytic Effects of GH in Human Subjects in Vivo N/A
Completed NCT03203356 - Adrenal Function in GHD Children N/A
Completed NCT05105685 - Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS Phase 1/Phase 2
Completed NCT04244123 - Web-based Adherence Information Integrated Nurse-led Monitoring Clinic
Not yet recruiting NCT03005561 - Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment N/A
Completed NCT03033121 - Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children Phase 3
Not yet recruiting NCT05660356 - Growth Hormone Deficiency in Mild Traumatic Brain Injury Early Phase 1
Active, not recruiting NCT00867971 - Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure? N/A
Recruiting NCT05253287 - Growth Hormone in Decompensated Liver Cirrhosis Phase 2/Phase 3
Active, not recruiting NCT03091374 - Impact of Recombinant Human Growth Hormone on HIV Persistence Phase 2
Not yet recruiting NCT02326610 - Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae Phase 2
Recruiting NCT06103513 - Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children Phase 3
Recruiting NCT04938466 - Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy
Recruiting NCT06037473 - The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg
Recruiting NCT05144035 - A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants Phase 4
Recruiting NCT03878992 - Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle N/A